Since the trial participants were not exposed to the coronavirus after vaccination, the scientists said it is not possible for the current study to determine the efficacy of the candidate vaccine.
Think beyond engineering and medicine.
The story of Kiran Mazumdar-Shaw is one of grit, self confidence and courage. If today she is one of the most successful entrepreneurs in the world, it is because of her determination.
Can Interferon alfa-2b treat COVID-19 effectively?
Almost each of these companies has a different technology to show for the effectiveness against microbes.
Eminent Indian-origin academician Srikant Datar has been named as Dean of Harvard Business School, succeeding Nitin Nohria and becoming the second consecutive dean hailing from India to lead the prestigious 112-year-old institution. Datar, an alumnus of University of Bombay and Indian Institute of Management, Ahmedabad, is the Arthur Lowes Dickinson Professor of Business Administration and the senior associate dean for University Affairs at Harvard Business School (HBS). He will assume charge as the school's next dean on January 1, president Larry Bacow said.
US space shuttle Discovery lifted off for its final flight from NASA's Kennedy Space Centre in Florida to deliver a new module and critical supplies to the International Space Station, late Thursday night.
Institute of Bioinformatics and Applied Biotechnology (IBAB), Bangalore, a Department of Information Technology (Government of India) Center of Excellence for Research and Training in Bioinformatics, invites applications.
Pfizer and BioNTech said they have concluded phase 3 study of their mRNA-based COVID-19 vaccine candidate BNT162b2, meeting all primary efficacy endpoints.
After registering encouraging data from oral insulin trials, Biocon is looking to partner on this with global pharma firms.
The sources said Gandhi wants India to lead in the niche area which comes after software development.
From genetically engineered angelfish to asteroids trips to revealing the God particle, science evolved further in 2010. Let's take a look at some of the advances in science
Vardhan stated the government is taking full precautions in human trials of vaccines and the National Expert Group on Vaccine Administration for COVID-19 under the chairmanship of Dr V K Paul, member-health, NITI Aayog, is drawing up a detailed strategy on how to immunize the majority of the population.
Pharmaceutical and biotechnology major, Wockhardt has received final approval from the United States Food & Drug Administration for marketing the cardiac drug.
'If the trial succeeds, it will become the success of Ayurveda.' 'If it's a failure, it's my failure alone.'
Sanofi-aventis has a significant presence in India and has 1,800 employees.
India's biotechnology industry is pushing the government for fiscal incentives, import duty exemption and correction of policy that gives MNCs higher drug prices than "desi" producers, ahead of the Union budget.
Sanofi-aventis on Monday said it has extended its $18.5 billion offer for Genzyme for the second time, a move that will give the French drug-maker additional time to reach an agreement with US biotechnology firm.
Symbiosis International University announces admissions to MBA - Energy & Environment (two years, full-time, residential programme)
Under this, Biological E would produce vaccine for India and other South Asian countries, including Bangladesh, Bhutan, the Maldives, Nepal, Pakistan and Sri Lanka.
Scientists around the world, including in India, suggest it hasn't been tested properly given the time constraint and there may not be enough evidence to prove its efficacy.
Institute of Health Management Research, Jaipur announces new admissions to Postgraduate Programme in Pharmaceutical Management.
The biotech regulatory Bill gags dissent and takes away the power of states without providing any safeguards to farmers and consumers.
The Bacillus Thuringiensis (Bt) brinjal episode will not impede the research work being carried out in the field of food and crop biotechnology in the country, a top scientist said.
CREMA (Clinical Research Education and Management Academy) opens admissions for its one-year, part-time PG Diploma.
While the moratorium on the commercial introduction of Bt brinjal will continue for now, it may not last indefinitely. Prime Minister Manmohan Singh, who addressed the issue among his combative ministerial colleagues this evening, is said to have asked for a swift assessment of all scientific and safety issues relating to the genetically-modified (GM) variety of the vegetable.
The company has launched the product in 10ml and 3ml vials, Biocon said.
Biocon Ltd on Tuesday said it has earned the distinction of being the only Asian biopharma company to feature among the top biotechnology employers in the world as ranked by Science magazine.
The new, less water consuming variety of paddy will be developed using conventional breeding and biotechnology techniques. Although, it may take at least five years to develop the new variety but it will reduce the dependence of paddy on rainfall or irrigated water to a large extent, experts pointed out.
Citing an opinion poll that says 80 per cent of people surveyed favoured the right to say no to government decision on genetically modified food, an NGO on Friday sought withdrawal of the proposed "flawed" bill aimed at setting up of a biotechnology regulatory authority.
There were apprehensions in the SII about rival Bharat Biotech's 'indigenous' tag, opening up shortcuts for it. One senior person, who was very familiar with the sector, told me, 'The message has gone out from the very top. Somani (V G Somani -- drug controller general of India) has told me "Bharat ka karna hai".' A fascinating excerpt from Abantika Ghosh's Billions Under Lockdown: The Inside Story Of India's Fight Against COVID-19.
Professor Shankar Balasubramanian has been awarded the prize, worth 10,000 pounds, for his work on Solexa sequencing, the high speed genome sequencing technology that means it is now possible to sequence a human genome for less than $10,000.
SMU (Sikkim Manipal University) of Distance Education has announced admissions for its 'Spring Drive' in 2009.
"Also, 35 per cent deaths were recorded in the age group of 45-60 years, 10 per cent in the age group of 26-44 years and one per cent each in the age group of 18-25 years and below 17 years," the health secy said.
IIT K opens admissions for it Masters programmes.
The initiative is being undertaken by the government of Karnataka, considered one of the leaders in the technology space. Currently, India doesn't have such a platform and, globally, there are very few privately-run platforms.
Allahabad Agriculture Institute's admission announcement for undergraduate, postgraduate and diploma programmes for 2008.
Indian drug companies, which have introduced copies of biotechnology drugs in the country, are bullish over the marketing prospects of 'biogenerics' after patents expire in developed markets. Experts say Indian companies may not repeat the success they achieved in selling generic medicines in biogenerics. The cost of clinical trials and the absence of substitutability will ensure that only those with deep pockets to launch such products globally will succeed, they feel.
'We don't know how complicated things will get with the onset of the monsoon.'
The company's share price touched a 52-weeks high on Monday on speculation that the global drug major, Pfizer, may buy stake or strike a marketing deal with the company.
